Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D. Scott, Michael W. Miller, Xing Dai et al.|Journal of Medicinal Chemistry|2017Cited by 147
Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinomaXiaolong Li, Xiaoping Zhang|Scientific Reports|2017Cited by 95